Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13Daiichi Sankyo

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

QUIZARTINIB DIHYDROCHLORIDE

Brand Name : VANFLYTA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 17.7MG BASE

Packaging :

Approval Date : 2023-07-20

Application Number : 216993

Regulatory Info : RX

Registration Country : USA

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

QUIZARTINIB DIHYDROCHLORIDE

Brand Name : VANFLYTA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 26.5MG BASE

Packaging :

Approval Date : 2023-07-20

Application Number : 216993

Regulatory Info : RX

Registration Country : USA

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Quizzical

Brand Name : VANFLYTA

Dosage Form : Film Coated Tablet

Dosage Strength : 20mg

Packaging :

Approval Date : 31/03/2025

Application Number : 69710

Regulatory Info : Allowed

Registration Country : Switzerland

blank

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Quizzical

Brand Name : VANFLYTA

Dosage Form : Film Coated Tablet

Dosage Strength : 30mg

Packaging :

Approval Date : 31/03/2025

Application Number : 69710

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Quizartinib dihydrochloride

Brand Name : The Vanflyta

Dosage Form : Film Coated Tablet

Dosage Strength : 17.7mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Quizartinib dihydrochloride

Brand Name : The Vanflyta

Dosage Form : Film Coated Tablet

Dosage Strength : 26.5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Quizartinib

Brand Name : Vanflyta

Dosage Form : Film-Coated Tablet

Dosage Strength : 177mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Quizartinib

Brand Name : Vanflyta

Dosage Form : Film-Coated Tablet

Dosage Strength : 265mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Quizartinib Dihydrochloride

Brand Name : Vanfly

Dosage Form : Film Coated Tablet

Dosage Strength : 17.7mg

Packaging :

Approval Date : 03-11-2023

Application Number : 28106798322

Regulatory Info : Prescription

Registration Country : Denmark

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Quizartinib Dihydrochloride

Brand Name : Vanfly

Dosage Form : Film Coated Tablet

Dosage Strength : 26.5mg

Packaging :

Approval Date : 06-11-2023

Application Number : 28106798422

Regulatory Info : Prescription

Registration Country : Denmark

blank

11

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Kizartinibdihydroklorid

Brand Name : Vanflyta

Dosage Form : Film Coated Tablet

Dosage Strength : 17.7mg

Packaging :

Approval Date : 06-11-2023

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

12

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Kizartinibdihydroklorid

Brand Name : Vanflyta

Dosage Form : Film Coated Tablet

Dosage Strength : 26.5mg

Packaging :

Approval Date : 06-11-2023

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

13

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

QUIZARTINIB (QUIZARTINIB HYDROCHLORIDE)

Brand Name : VANFLYTA

Dosage Form : TABLET

Dosage Strength : 17.7MG

Packaging :

Approval Date :

Application Number : 2558351

Regulatory Info : PRESCRIPTION

Registration Country : Canada

blank